AvidasTM Pharmaceuticals and LaRonTM Pharma Inc. Announce Co-Promotion Agreement
DOYLESTOWN, Pa., July 21, 2009 – Avidas Pharmaceuticals and LaRon Pharma Inc. today announced
that they have entered in an agreement for LaRon to co-promote Avidas’ key prescription-only
convenience kits, Avidoxy DKTM defence kit and ScalacortTM DK defence kit. Under the terms of the
agreement, LaRon will provide sales support focused on primary care and internal medicine physicians
in the United States, while Avidas will continue its sales force specialty focus in dermatology. Avidas will
also maintain full marketing rights for each of the products. Specific financial terms of the deal were not
disclosed.
“We are very excited to strengthen our position in the severe acne and scalp dermatitis markets with
this LaRon collaboration,” said Margie Gardner, CEO of Avidas. “The addition of LaRon’s sales force
efforts, together with the efforts of our own sales team, will significantly expand our footprint into
primary care while allowing us to maintain our focus on the specialty market of dermatology.”
The Avidoxy DK defence kit includes Avidoxy (Doxycycline Tablets), a broad spectrum oral antibiotic, in
an easy-to-swallow film-coated caplet indicated as adjunctive therapy for severe acne, along with
complimentary defenceTM acne wash, a specially formulated oil- and alcohol-free acne wash with 2%
salicylic acid that provides gentle, yet effective, cleansing and exfoliation of skin. Avidoxy DK defence kit
also includes complimentary defenceTM solare SPF 30+, a lightweight, oil-free, non-comedogenic
sunscreen rich in anti-oxidants and moisturizers offering the broad spectrum sun protection that is so
important for patients with acne.
Scalacort DK defence kit includes Scalacort (hydrocortisone lotion USP) 2%, a fast-drying, non-greasy,
corticosteroid in a clear, fragrance-free base. Scalacort relieves itching and inflammation of the scalp in
areas where greasy ointments and creams may not be cosmetically appealing. For added patient
convenience, the Scalacort DK defence kit also includes complimentary defenceTM medicated shampoo,
a professional-strength medicated shampoo formulated with 2% salicylic acid and 2% micronized
colloidal sulfur to control the flaking and scaling of seborrheic dermatitis and scalp psoriasis, and
complimentary defenceTM gentle cleansing shampoo, a color- and fragrance-free, non-irritating
shampoo designed to be used daily on all hair types.
“We are pleased to add the Avidoxy DK and Scalacort DK defence kits to our product portfolio as we
expand on our commitment towards a healthy population,” said Ronnee Adesanya MD, CEO LaRon
Pharma Inc. “We see this co-promotion as a terrific opportunity to grow our collaboration with Avidas
Pharmaceuticals while also allowing us to further meet the needs of patients across the country.”
Both products are available by prescription only, and are designed to optimize patient convenience by
simplifying therapy and maximizing the benefits of treatment. For more information, please visit
www.avidoxydk.com and www.scalacortdk.com.
About Avidas:
Avidas Pharmaceuticals is a privately held company focused on the therapeutic areas of dermatology
and women’s health. The company acquires, develops, and maximizes the potential of acquired
products through focused selling and precision marketing. The company is headquartered in
Doylestown, PA. www.avidaspharma.com
About LaRon:
LaRon Pharma Inc. is a privately held company focused on development, acquisition of and collaborative
agreements for products that enhance effective use and targeted therapeutic response in patients. The
company's mission is “commitment towards a healthy population.” The company is located in Fort
Washington, PA. www.laronpharma.com
Avidoxy Important Safety Information:
Avidoxy is indicated as adjunctive therapy for severe acne. To reduce the development of drug-resistant
bacteria and maintain the effectiveness of Avidoxy and other antibacterial drugs, Avidoxy should be
used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
The use of drugs of the Tetracycline class during tooth development (last half of pregnancy, infancy, and
childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown).
For full prescribing information, please visit www.avidoxydk.com
About Acne:
Acne vulgaris (commonly called acne) is a skin disease caused by changes in the pilosebaceous units
(skin structures consisting of a hair follicle and its associated sebaceous gland). Severe acne is
inflammatory, but acne can also manifest in non-inflammatory forms. Acne lesions are commonly
referred to as pimples, spots, zits, or acne.
Scalacort Important Safety Information:
Scalacort is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroidresponsive
dermatoses.
Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary- adrenal
(HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria in some
patients. Conditions which augment systemic absorption include the application of the more potent
steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings. Therefore,
patients receiving a large dose of a potent topical steroid applied to a large surface area or under an
occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the
urinary free cortisol and ACTH stimulation tests.
For full Prescribing Information, please visit www.scalacortdk.com
About Seborrheic Dermatitis:
Seborrheic dermatitis is a chronic inflammatory disorder affecting areas of the head and trunk where
sebaceous glands are most prominent. Lipophilic yeasts of the Malassezia genus, as well as genetic,
environmental and general health factors, contribute to this disorder. Scalp seborrhea varies from mild
dandruff to dense, diffuse, adherent scale.
Facial and trunk seborrhea is characterized by powdery or greasy scale in skin folds and along hair
margins.
About Scalp Psoriasis:
Psoriasis is a chronic, non-contagious autoimmune disease which affects the skin and joints. It
commonly causes red scaly patches to appear on the skin. The scaly patches caused by psoriasis, called
psoriatic plaques, are areas of inflammation and excessive skin production. Skin rapidly accumulates at
these sites and takes on a silvery-white appearance. Approximately half of the people who have
psoriasis have scalp psoriasis.
Contact:
Avidas Pharmaceuticals, LLC, Greg Gironda, 267-895-1755, greggironda@avidaspharma.com
LaRon Pharma Inc., 215-542-2868, admin@laronpharma.com